Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies

Clinica Chimica Acta

Volumn 413, Issue 7-8, 2012, Pages 719-726

  Mahler, M ^a   Radice, A ^b   Yang, W ^a   Bentow, C ^a   Seaman, A ^a   Bianchi, L ^b   Sinico, R A ^b  

^a INOVA DIAGNOSTICS INC   (United States)

^b SAN CARLO BORROMEO HOSPITAL   (Italy)

Author keywords

ELISA; GPA; Microscopic polyangiitis; MPA; MPO ANCA; PR3 ANCA; Wegener's granulomatosis

Indexed keywords

ENZYME ANTIBODY; MYELOPEROXIDASE ANTIBODY; PROTEINASE 3 ANTIBODY; UNCLASSIFIED DRUG;

ACCURACY; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEASUREMENT; MICROSCOPIC POLYANGIITIS; PATIENT MONITORING; PRIORITY JOURNAL; REFERENCE VALUE; SCORING SYSTEM;

AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LUMINESCENCE; MYELOBLASTIN; PEROXIDASE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 84862813629     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.01.004     Document Type: Article

References (28)

1. Falk R.J., Gross W.L., Guillevin L., et al. Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Arthritis Rheum 2011, 63:863-864.
2. Wiik A. What you should know about PR3-ANCA. An introduction. Arthritis Res 2000, 2:252-254.
3. Csernok E., Holle J., Hellmich B., et al. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study. Rheumatology (Oxford) 2004, 43:174-180.
4. Arranz O., Ara J., Rodriguez R., et al. Comparison of anti-PR3 capture and anti-PR3 direct ELISA for detection of antineutrophil cytoplasmic antibodies (ANCA) in long-term clinical follow-up of PR3-ANCA-associated vasculitis patients. Clin Nephrol 2001, 56:295-301.
5. Sun J., Fass D.N., Hudson J.A., et al. Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes. J Immunol Methods 1998, 211:111-123.
6. Roggenbuck D., Buettner T., Hoffmann L., Schmechta H., Reinhold D., Conrad K. High-sensitivity detection of autoantibodies against proteinase-3 by a novel third-generation enzyme-linked immunosorbent assay. Ann N Y Acad Sci 2009, 1173:41-46.
7. Holle J.U., Csernok E., Fredenhagen G., Backes M., Bremer J.P., Gross W.L. Clinical evaluation of hsPR3-ANCA ELISA for detection of antineutrophil cytoplasmatic antibodies directed against proteinase 3. Ann Rheum Dis 2010, 69:468-469.
8. Rutgers A., Damoiseaux J., Roozendaal C., Limburg P.C., Stegeman C.A., Tervaert J.W. ANCA-GBM dot-blot: evaluation of an assay in the differential diagnosis of patients presenting with rapidly progressive glomerulonephritis. J Clin Immunol 2004, 24:435-440.
9. Kaul R., Johnson K., Scholz H., Marr G. Performance of the BioPlex 2200 Autoimmune Vasculitis kit. Autoimmun Rev 2009, 8:224-227.
10. Damoiseaux J., Vaessen M., Knapen Y., et al. Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture's disease. Ann N Y Acad Sci 2007, 1109:454-463.
11. Trevisin M., Pollock W., Dimech W., Savige J. Evaluation of a multiplex flow cytometric immunoassay to detect PR3- and MPO-ANCA in active and treated vasculitis, and in inflammatory bowel disease (IBD). J Immunol Methods 2008, 336:104-112.
12. Damoiseaux J., Dahnrich C., Rosemann A., et al. A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis. Ann Rheum Dis 2009, 68:228-233.
13. Ito-Ihara T., Muso E., Kobayashi S., et al. A comparative study of the diagnostic accuracy of ELISA systems for the detection of anti-neutrophil cytoplasm antibodies available in Japan and Europe. Clin Exp Rheumatol 2008, 26:1027-1033.
14. Sinico R.A., Radice A., Corace C., DI T.L., Sabadini E. Value of a new automated fluorescence immunoassay (EliA) for PR3 and MPO-ANCA in monitoring disease activity in ANCA-associated systemic vasculitis. Ann N Y Acad Sci 2005, 1050:185-192.
15. Hunder G.G., Arend W.P., Bloch D.A., et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 1990, 33:1065-1067.
16. Hagen E.C., Daha M.R., Hermans J., et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998, 53:743-753.
17. Jennette J.C., Falk R.J., Andrassy K., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37:187-192.
18. Mukhtyar C., Lee R., Brown D., et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 2009, 68:1827-1832.
19. Radice A., Vecchi M., Bianchi M.B., Sinico R.A. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives. Clin Exp Rheumatol 2000, 18:707-712.
20. Holle J.U., Csernok E., Fredenhagen G., Backes M., Bremer J.P., Gross W.L. Clinical evaluation of hsPR3-ANCA ELISA for detection of antineutrophil cytoplasmatic antibodies directed against proteinase 3. Ann Rheum Dis 2010, 69:468-469.
21. Holle J.U., Csernok E., Fredenhagen G., Backes M., Bremer J.P., Gross W.L. Clinical evaluation of hsPR3-ANCA ELISA for detection of antineutrophil cytoplasmatic antibodies directed against proteinase 3. Ann Rheum Dis 2010, 69:468-469.
22. Lee A.S., Finkielman J.D., Peikert T., Hummel A.M., Viss M.A., Specks U. A novel capture-ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-terminally tagged recombinant neutrophil serine proteases. J Immunol Methods 2005, 307:62-72.
23. O'Donnell J.L., Hayman M.W., Spellerberg M.B., et al. Antineutrophil cytoplasmic antibody measurement: advantages and disadvantages of a capture PR3 ELISA and a direct PR3 ELISA. Pathology 2007, 39:258-263.
24. Vermeersch P., Vervaeke S., Blockmans D., et al. Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: comparative analysis of different strategies. Clin Chim Acta 2008, 397:77-81.
25. Russell K.A., Wiegert E., Schroeder D.R., Homburger H.A., Specks U. Detection of anti-neutrophil cytoplasmic antibodies under actual clinical testing conditions. Clin Immunol 2002, 103:196-203.
26. Westman K.W., Bygren P.G., Eilert I., Wiik A., Wieslander J. Rapid screening assay for anti-GBM antibody and ANCAs; an important tool for the differential diagnosis of pulmonary renal syndromes. Nephrol Dial Transplant 1997, 12:1863-1868.
27. Chan E.K., Fritzler M.J., Wiik A., et al. AutoAbSC. Org - Autoantibody Standardization Committee in 2006. Autoimmun Rev 2007, 6:577-580.
28. Sack U., Conrad K., Csernok E., et al. Standardization of autoimmune diagnostics in Germany: activities of the German group in the European Autoimmune Standardization Initiative. Ann N Y Acad Sci 2007, 1109:31-36.